Literature DB >> 26582609

The dependence of chemokine-glycosaminoglycan interactions on chemokine oligomerization.

Douglas P Dyer1, Catherina L Salanga1, Brian F Volkman2, Tetsuya Kawamura1, Tracy M Handel3.   

Abstract

Both chemokine oligomerization and binding to glycosaminoglycans (GAGs) are required for their function in cell recruitment. Interactions with GAGs facilitate the formation of chemokine gradients, which provide directional cues for migrating cells. In contrast, chemokine oligomerization is thought to contribute to the affinity of GAG interactions by providing a more extensive binding surface than single subunits alone. However, the importance of chemokine oligomerization to GAG binding has not been extensively quantified. Additionally, the ability of chemokines to form different oligomers has been suggested to impart specificity to GAG interactions, but most studies have been limited to heparin. In this study, several differentially oligomerizing chemokines (CCL2, CCL3, CCL5, CCL7, CXCL4, CXCL8, CXCL11 and CXCL12) and select oligomerization-deficient mutants were systematically characterized by surface plasmon resonance to determine their relative affinities for heparin, heparan sulfate (HS) and chondroitin sulfate-A (CS-A). Wild-type chemokines demonstrated a hierarchy of binding affinities for heparin and HS that was markedly dependent on oligomerization. These results were corroborated by their relative propensity to accumulate on cells and the critical role of oligomerization in cell presentation. CS-A was found to exhibit greater chemokine selectivity than heparin or HS, as it only bound a subset of chemokines; moreover, binding to CS-A was ablated with oligomerization-deficient mutants. Overall, this study definitively demonstrates the importance of oligomerization for chemokine-GAG interactions, and demonstrates diversity in the affinity and specificity of different chemokines for GAGs. These data support the idea that GAG interactions provide a mechanism for fine-tuning chemokine function.
© The Author 2015. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  chemokine; heparan sulfate; heparin; oligomerization; surface plasmon resonance

Mesh:

Substances:

Year:  2015        PMID: 26582609      PMCID: PMC4736540          DOI: 10.1093/glycob/cwv100

Source DB:  PubMed          Journal:  Glycobiology        ISSN: 0959-6658            Impact factor:   4.313


  83 in total

1.  The BBXB motif of RANTES is the principal site for heparin binding and controls receptor selectivity.

Authors:  A E Proudfoot; S Fritchley; F Borlat; J P Shaw; F Vilbois; C Zwahlen; A Trkola; D Marchant; P R Clapham; T N Wells
Journal:  J Biol Chem       Date:  2000-12-14       Impact factor: 5.157

2.  A rapid and efficient way to obtain modified chemokines for functional and biophysical studies.

Authors:  Samantha J Allen; Damon J Hamel; Tracy M Handel
Journal:  Cytokine       Date:  2011-05-31       Impact factor: 3.861

3.  Syndecan-4 is a signaling molecule for stromal cell-derived factor-1 (SDF-1)/ CXCL12.

Authors:  Nathalie Charnaux; Séverine Brule; Morgan Hamon; Thomas Chaigneau; Line Saffar; Catherine Prost; Nicole Lievre; Liliane Gattegno
Journal:  FEBS J       Date:  2005-04       Impact factor: 5.542

4.  Design and receptor interactions of obligate dimeric mutant of chemokine monocyte chemoattractant protein-1 (MCP-1).

Authors:  Joshua H Y Tan; Meritxell Canals; Justin P Ludeman; Jamie Wedderburn; Christopher Boston; Stephen J Butler; Ann Marie Carrick; Todd R Parody; Deni Taleski; Arthur Christopoulos; Richard J Payne; Martin J Stone
Journal:  J Biol Chem       Date:  2012-03-06       Impact factor: 5.157

Review 5.  Regulation of protein function by glycosaminoglycans--as exemplified by chemokines.

Authors:  T M Handel; Z Johnson; S E Crown; E K Lau; A E Proudfoot
Journal:  Annu Rev Biochem       Date:  2005       Impact factor: 23.643

6.  Beta-chemokines are released from HIV-1-specific cytolytic T-cell granules complexed to proteoglycans.

Authors:  L Wagner; O O Yang; E A Garcia-Zepeda; Y Ge; S A Kalams; B D Walker; M S Pasternack; A D Luster
Journal:  Nature       Date:  1998-02-26       Impact factor: 49.962

7.  Glycosaminoglycans mediate cell surface oligomerization of chemokines.

Authors:  A J Hoogewerf; G S Kuschert; A E Proudfoot; F Borlat; I Clark-Lewis; C A Power; T N Wells
Journal:  Biochemistry       Date:  1997-11-04       Impact factor: 3.162

8.  Evolutionary differences in glycosaminoglycan fine structure detected by quantitative glycan reductive isotope labeling.

Authors:  Roger Lawrence; Sara K Olson; Robert E Steele; Lianchun Wang; Rahul Warrior; Richard D Cummings; Jeffrey D Esko
Journal:  J Biol Chem       Date:  2008-09-24       Impact factor: 5.157

9.  Ultralarge complexes of PF4 and heparin are central to the pathogenesis of heparin-induced thrombocytopenia.

Authors:  Lubica Rauova; Mortimer Poncz; Steven E McKenzie; Michael P Reilly; Gowthami Arepally; John W Weisel; Chandrasekaran Nagaswami; Douglas B Cines; Bruce S Sachais
Journal:  Blood       Date:  2004-08-10       Impact factor: 22.113

10.  The novel CXCL12gamma isoform encodes an unstructured cationic domain which regulates bioactivity and interaction with both glycosaminoglycans and CXCR4.

Authors:  Cédric Laguri; Rabia Sadir; Patricia Rueda; Françoise Baleux; Pierre Gans; Fernando Arenzana-Seisdedos; Hugues Lortat-Jacob
Journal:  PLoS One       Date:  2007-10-31       Impact factor: 3.240

View more
  47 in total

1.  Different contributions of chemokine N-terminal features attest to a different ligand binding mode and a bias towards activation of ACKR3/CXCR7 compared with CXCR4 and CXCR3.

Authors:  Martyna Szpakowska; Amanda M Nevins; Max Meyrath; David Rhainds; Thomas D'huys; François Guité-Vinet; Nadine Dupuis; Pierre-Arnaud Gauthier; Manuel Counson; Andrew Kleist; Geneviève St-Onge; Julien Hanson; Dominique Schols; Brian F Volkman; Nikolaus Heveker; Andy Chevigné
Journal:  Br J Pharmacol       Date:  2018-03-23       Impact factor: 8.739

Review 2.  New paradigms in chemokine receptor signal transduction: Moving beyond the two-site model.

Authors:  Andrew B Kleist; Anthony E Getschman; Joshua J Ziarek; Amanda M Nevins; Pierre-Arnaud Gauthier; Andy Chevigné; Martyna Szpakowska; Brian F Volkman
Journal:  Biochem Pharmacol       Date:  2016-04-19       Impact factor: 5.858

Review 3.  What Do Structures Tell Us About Chemokine Receptor Function and Antagonism?

Authors:  Irina Kufareva; Martin Gustavsson; Yi Zheng; Bryan S Stephens; Tracy M Handel
Journal:  Annu Rev Biophys       Date:  2017-05-22       Impact factor: 12.981

Review 4.  The Role of Heparan Sulfate in Inflammation, and the Development of Biomimetics as Anti-Inflammatory Strategies.

Authors:  Brooke L Farrugia; Megan S Lord; James Melrose; John M Whitelock
Journal:  J Histochem Cytochem       Date:  2018-01-01       Impact factor: 2.479

Review 5.  The heparan sulfate proteoglycan grip on hyperlipidemia and atherosclerosis.

Authors:  Philip L S M Gordts; Jeffrey D Esko
Journal:  Matrix Biol       Date:  2018-05-24       Impact factor: 11.583

Review 6.  Chemokine and chemokine receptor structure and interactions: implications for therapeutic strategies.

Authors:  Irina Kufareva; Catherina L Salanga; Tracy M Handel
Journal:  Immunol Cell Biol       Date:  2015-02-24       Impact factor: 5.126

7.  Two glycosaminoglycan-binding domains of the mouse cytomegalovirus-encoded chemokine MCK-2 are critical for oligomerization of the full-length protein.

Authors:  Sergio M Pontejo; Philip M Murphy
Journal:  J Biol Chem       Date:  2017-04-21       Impact factor: 5.157

8.  Structural basis for oligomerization and glycosaminoglycan binding of CCL5 and CCL3.

Authors:  Wenguang G Liang; Catherine G Triandafillou; Teng-Yi Huang; Medel Manuel L Zulueta; Shiladitya Banerjee; Aaron R Dinner; Shang-Cheng Hung; Wei-Jen Tang
Journal:  Proc Natl Acad Sci U S A       Date:  2016-04-18       Impact factor: 11.205

9.  Kinetics of CXCL12 binding to atypical chemokine receptor 3 reveal a role for the receptor N terminus in chemokine binding.

Authors:  Martin Gustavsson; Douglas P Dyer; Chunxia Zhao; Tracy M Handel
Journal:  Sci Signal       Date:  2019-09-10       Impact factor: 8.192

10.  Examination of Glycosaminoglycan Binding Sites on the XCL1 Dimer.

Authors:  Jamie C Fox; Robert C Tyler; Francis C Peterson; Douglas P Dyer; Fuming Zhang; Robert J Linhardt; Tracy M Handel; Brian F Volkman
Journal:  Biochemistry       Date:  2016-02-17       Impact factor: 3.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.